Published in Am J Clin Nutr on September 01, 1986
Localization of cellular retinol-binding protein and retinol-binding protein in cells comprising the blood-brain barrier of rat and human. Proc Natl Acad Sci U S A (1990) 1.23
Kinetic analysis of human enzyme RDH10 defines the characteristics of a physiologically relevant retinol dehydrogenase. J Biol Chem (2008) 1.10
Identification, retinoid binding, and x-ray analysis of a human retinol-binding protein. Proc Natl Acad Sci U S A (2001) 1.00
The relations between dietary antioxidant vitamins intake and oxidative stress in follicular fluid and ART outcomes. Iran J Reprod Med (2015) 0.75
Cellular retinoid binding-proteins, CRBP, CRABP, FABP5: Effects on retinoid metabolism, function and related diseases. Pharmacol Ther (2017) 0.75
Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med (1985) 7.22
Acute enterocolitis in a human being infected with the protozoan Cryptosporidium. Gastroenterology (1976) 6.15
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 4.67
BRCA1 is secreted and exhibits properties of a granin. Nat Genet (1996) 4.26
Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer (1985) 3.92
Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol (2000) 3.55
Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol (1992) 3.39
Creation of "amyloid" fibrils from Bence Jones proteins in vitro. Science (1971) 3.14
Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med (1994) 3.09
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet (1995) 2.91
Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med (1991) 2.77
Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat Med (1995) 2.74
Myocardial changes associated with cardiogenic shock. N Engl J Med (1971) 2.67
Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (1996) 2.33
Clinical experience over 48 years with pheochromocytoma. Ann Surg (1999) 2.32
Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas. Histopathology (2000) 2.27
Expression of mitoses per thousand cells and cell density in breast carcinomas: a proposal. Hum Pathol (1992) 2.18
Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer (1982) 2.17
Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc Natl Acad Sci U S A (1995) 2.07
American Joint Committee on Cancer prognostic factors consensus conference. Cancer (1999) 2.02
Infiltrating lobular carcinoma of the breast. Histopathology (1982) 1.98
Amyloid, amyloidosis, and amyloidogenesis. Int Rev Exp Pathol (1976) 1.97
Invasive breast cancer risk in women with sclerosing adenosis. Cancer (1989) 1.93
Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis. Hum Pathol (1997) 1.91
Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement. Mod Pathol (2000) 1.88
Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst (1978) 1.82
Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci U S A (1991) 1.77
When and to what end do pathologists agree? J Natl Cancer Inst (1998) 1.76
Minimal solid tumor involvement of regional and distant sites: when is a metastasis not a metastasis? Cancer (1999) 1.73
Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst (2001) 1.68
Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia. J Natl Cancer Inst (1999) 1.67
Histologic grading of breast carcinoma. A reproducibility study. Cancer (1994) 1.61
Invasive cribriform carcinoma of the breast. Histopathology (1983) 1.53
Evidence for a lecithin-retinol acyltransferase activity in the rat small intestine. J Biol Chem (1988) 1.53
Structural identity of Bence Jones and amyloid fibril proteins in a patient with plasma cell dyscrasia and amyloidosis. J Clin Invest (1973) 1.51
Effects of pharmacological retinoids on several vitamin A-metabolizing enzymes. Cancer Res (1993) 1.48
Retinoic acid-binding protein in rat tissue. Partial purification and comparison to rat tissue retinol-binding protein. J Biol Chem (1975) 1.46
Reactive spindle cell nodules of the breast after core biopsy or fine-needle aspiration. Am J Clin Pathol (2000) 1.45
Ductal carcinoma in situ of the breast: understanding the misunderstood stepchild. JAMA (1996) 1.42
Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. J Clin Oncol (2000) 1.42
Recurrent mammary carcinoma after local excision. A segmental problem. Cancer (1995) 1.41
Cellular proliferation and prognosis in breast cancer: statistical purity versus clinical utility. Hum Pathol (1994) 1.41
Immunochemical cross-reactions of human amyloid proteins with human immunoglobulin light polypeptide chains. J Immunol (1972) 1.39
Long-term survivors after breast cancer. Br J Surg (1985) 1.38
Cellular retinol- and retinoic acid-binding proteins in vitamin A action. Fed Proc (1979) 1.37
Plasma retinol binding protein: structure and function of the prototypic lipocalin. Biochim Biophys Acta (2000) 1.37
Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer (1989) 1.36
Radioimmunochemical determination of cellular retinol- and cellular retinoic acid-binding proteins in cytosols of rat tissues. J Biol Chem (1982) 1.33
The relation of the properties of Congo red-stained amyloid fibrils to the -conformation. J Histochem Cytochem (1972) 1.32
The development of cardiac myxomas and papillary endocardial lesions from mural thrombus. Am Heart J (1975) 1.31
Infarction of bone marrow in the sickle cell disorders. Ann Intern Med (1967) 1.30
Cellular retinoic acid-binding protein from rat testis. Purification and characterization. J Biol Chem (1978) 1.27
Adenomas of the breast and ectopic breast under lactational influences. Hum Pathol (1985) 1.26
Spatial distribution of cellular protein binding to retinoic acid in the chick limb bud. Nature (1988) 1.25
Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am J Epidemiol (1987) 1.25
Murine amyloidosis: immunologic characterization of amyloid fibril protein. J Immunol (1971) 1.25
Pathogenesis of Paget's disease: epidermal heregulin-alpha, motility factor, and the HER receptor family. J Natl Cancer Inst (2000) 1.24
Localization of cellular retinol-binding protein and retinol-binding protein in cells comprising the blood-brain barrier of rat and human. Proc Natl Acad Sci U S A (1990) 1.23
Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population. J Surg Oncol (1987) 1.22
Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. Am J Clin Pathol (1979) 1.22
Cellular differentiation in the emerging fetal rat small intestinal epithelium: mosaic patterns of gene expression. Proc Natl Acad Sci U S A (1989) 1.21
Cellular retinol-binding protein from rat liver. Purification and characterization. J Biol Chem (1978) 1.20
Differential interaction of lecithin-retinol acyltransferase with cellular retinol binding proteins. Biochemistry (1992) 1.20
IgA deficiency associated with partial deletion of chromosome 18. Am J Dis Child (1969) 1.20
College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants. Arch Pathol Lab Med (2000) 1.17
No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia. Cancer (2001) 1.17
Diabetic mastopathy. A clinicopathologic review. Am J Clin Pathol (2000) 1.15
Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. Cancer (1994) 1.15
Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence. Cancer (1999) 1.15
Interaction of the retinol/cellular retinol-binding protein complex with isolated nuclei and nuclear components. J Cell Biol (1981) 1.15
Comparison of adrenal cortical tumors in children and adults. Cancer (1986) 1.14
A lecithin:retinol acyltransferase activity in human and rat liver. Biochem Biophys Res Commun (1988) 1.14
Optical properties of normal and diseased breast tissues: prognosis for optical mammography. J Biomed Opt (1996) 1.13
Specificity of cellular retinol-binding protein for compounds with vitamin A activity. Nature (1975) 1.13
Binding specificities of cellular retinol-binding protein and cellular retinol-binding protein, type II. J Biol Chem (1987) 1.12
Immunoglobulin origin of localized nodular pulmonary amyloidosis. Res Exp Med (Berl) (1972) 1.11
Immunocytochemical localization of cellular retinol binding protein in the rat retina. Invest Ophthalmol Vis Sci (1984) 1.10
Mediation of retinoic acid-induced growth and anti-tumour activity. Nature (1976) 1.10
Characteristics of retinol accumulation from serum retinol-binding protein by cultured Sertoli cells. Biochemistry (1989) 1.10
College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Summary. Members of the Cancer Committee. Arch Pathol Lab Med (1995) 1.10
Pathology and heredity of breast cancer in younger women. J Natl Cancer Inst Monogr (1994) 1.09
Staphylococcal bacteremia and altered host resistance. Ann Intern Med (1968) 1.08
Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues. Cancer Res (1986) 1.08
Rat cellular retinol-binding protein II: use of a cloned cDNA to define its primary structure, tissue-specific expression, and developmental regulation. Proc Natl Acad Sci U S A (1986) 1.08
A novel retinol-binding protein from rat. Purification and partial characterization. J Biol Chem (1984) 1.07
Retinoic acid binding protein: occurrence in human tumors. Science (1975) 1.05
Atrial arrhythmias and lipomatous hypertrophy of the cardiac interatrial septum. Am Heart J (1971) 1.05
Detergent enema: a cause of caustic colitis. Pediatr Radiol (1977) 1.04
Cell-specific immunohistochemical localization of a cellular retinol-binding protein (type two) in the small intestine of rat. Proc Natl Acad Sci U S A (1985) 1.04
Cellular retinol-binding protein allows specific interaction of retinol with the nucleus in vitro. Proc Natl Acad Sci U S A (1979) 1.04
Surgical management of Menetrier's disease with protein-losing gastropathy. Ann Surg (1975) 1.04
Immunolocalization of transforming growth factor-alpha in normal and diseased human gastric mucosa. Hum Pathol (1995) 1.03
Mesenchymal hamartoma of liver. A regional ischemic lesion of a sequestered lobe. Am J Dis Child (1993) 1.02
Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol (2001) 1.02
Clinical correlates of false-negative fine needle aspirations of the breast in a consecutive series of 1,005 patients. Surg Gynecol Obstet (1993) 1.02
Retinoic acid biosynthesis by normal human breast epithelium is via aldehyde dehydrogenase 6, absent in MCF-7 cells. Cancer Res (2001) 1.02
Tumoral amyloidosis of bone of beta 2-microglobulin origin in association with long-term hemodialysis: a new type of amyloid disease. Hum Pathol (1986) 1.01
Bacteriological studies in a patient with antibiotic-associated pseudomembranous colitis. Gastroenterology (1977) 1.01